Found: 7
Select item for more details and to access through your institution.
Osteoprotegerin Is more than a Possible Serum Marker in Liver Fibrosis: A Study into Its Function in Human and Murine Liver.
- Published in:
- Pharmaceutics, 2020, v. 12, n. 5, p. 471, doi. 10.3390/pharmaceutics12050471
- By:
- Publication type:
- Article
Evaluating the antifibrotic potency of galunisertib in a human ex vivo model of liver fibrosis.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Hepatoprotective Efficacy of Cycloastragenol Alleviated the Progression of Liver Fibrosis in Carbon-Tetrachloride-Treated Mice.
- Published in:
- Biomedicines, 2023, v. 11, n. 1, p. 231, doi. 10.3390/biomedicines11010231
- By:
- Publication type:
- Article
Carbon tetrachloride-induced acute liver toxicity: selecting dosage and biomarkers for evaluating hepatoprotective drugs in ICR outbred mice.
- Published in:
- Pharmaceutical Sciences Asia, 2022, v. 49, n. 6, p. 534, doi. 10.29090/psa.2022.06.22.212
- By:
- Publication type:
- Article
Prevalence of anti-hypertensive drug prescription in Thailand, a cross sectional study using National Health Security Office database.
- Published in:
- Pharmaceutical Sciences Asia, 2022, v. 49, n. 2, p. 123, doi. 10.29090/psa.2022.02.21.086
- By:
- Publication type:
- Article
Modified culture protocol for testing anti-fibrotic drugs using precision-cut liver slices.
- Published in:
- Pharmaceutical Sciences Asia, 2020, v. 47, n. 3, p. 301, doi. 10.29090/psa.2020.03.019.0137
- By:
- Publication type:
- Article
A Pathophysiological Model of Non-Alcoholic Fatty Liver Disease Using Precision-Cut Liver Slices.
- Published in:
- Nutrients, 2019, v. 11, n. 3, p. 507, doi. 10.3390/nu11030507
- By:
- Publication type:
- Article